MedPath

UCB Australia Pty Ltd.

🇦🇺Australia
Ownership
Subsidiary
Employees
-
Market Cap
-
Website
http://www.ucbaustralia.com.au

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

36

TGA:36

Drug Approvals

Bimzelx bimekizumab 320 mg/2 mL solution for injection safety syringe (443491)

Product Name
BIMZELX bimekizumab 320 mg/2 mL solution for injection safety syringe
Approval Date
Apr 8, 2025
TGA

Bimzelx bimekizumab 320 mg/2 mL solution for injection auto-injector (443490)

Product Name
BIMZELX bimekizumab 320 mg/2 mL solution for injection auto-injector
Approval Date
Apr 8, 2025
TGA

RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial (427684)

Product Name
RYSTIGGO rozanolixizumab 140 mg/mL solution for injection for infusion vial
Approval Date
Feb 7, 2025
TGA

FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle (429413)

Product Name
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
Approval Date
Nov 28, 2024
TGA

ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe (410994)

Product Name
ZILBRYSQ zilucoplan (as tetrasodium) 16.6 mg/ 0.416 mL solution for injection pre-filled syringe
Approval Date
Aug 20, 2024
TGA

ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe (414649)

Product Name
ZILBRYSQ zilucoplan (as tetrasodium) 32.4 mg/ 0.810 mL solution for injection pre-filled syringe
Approval Date
Aug 20, 2024
TGA

ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe (414648)

Product Name
ZILBRYSQ zilucoplan (as tetrasodium) 23.0 mg/ 0.574 mL solution for injection pre-filled syringe
Approval Date
Aug 20, 2024
TGA

Bimzelx bimekizumab 160 mg/1 mL solution for injection auto-injector (353268)

Product Name
BIMZELX bimekizumab 160 mg/1 mL solution for injection auto-injector
Approval Date
Mar 24, 2022
TGA

Bimzelx bimekizumab 160 mg/1 mL solution for injection safety syringe (353269)

Product Name
BIMZELX bimekizumab 160 mg/1 mL solution for injection safety syringe
Approval Date
Mar 24, 2022
TGA

VIMPAT lacosamide 10 mg/mL oral solution bottle (286810)

Product Name
VIMPAT lacosamide 10 mg/mL oral solution bottle
Approval Date
Aug 14, 2018
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.